US Stock MarketDetailed Quotes

GANX Gain Therapeutics

Watchlist

3.390
+0.220+6.94%

Close Apr 23 16:00 ET

3.400
+0.010+0.29%

Post 19:54 ET

54.98MMarket Cap-1982P/E (TTM)

Gain Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

-60.62%55.18K

22.61%55.18K

-15.08%140.11K

6.65%95.1K

754.17%45.01K

Operating revenue

-58.40%55.18K

--0

47.00%55.18K

-0.96%132.64K

--0

16.52%95.1K

--37.54K

Cost of revenue

Gross profit

Operating expense

24.51%22.31M

-3.38%4.41M

2.82%4.89M

46.66%7.73M

58.54%5.28M

28.06%17.92M

40.26%4.56M

1.88%4.75M

46.28%5.27M

34.84%3.33M

Selling and administrative expenses

13.08%10.79M

-11.11%2.03M

-9.64%2.52M

39.19%3.74M

40.33%2.49M

39.74%9.54M

28.54%2.29M

27.43%2.79M

48.56%2.69M

69.13%1.78M

-General and administrative expense

13.08%10.79M

-11.11%2.03M

-9.64%2.52M

39.19%3.74M

40.33%2.49M

39.74%9.54M

28.54%2.29M

27.43%2.79M

48.56%2.69M

69.13%1.78M

Research and development costs

37.52%11.52M

4.40%2.37M

20.50%2.37M

54.44%3.99M

79.33%2.79M

16.93%8.38M

54.42%2.27M

-20.67%1.96M

43.98%2.58M

9.49%1.56M

Operating profit

-25.18%-22.25M

3.38%-4.41M

-2.82%-4.89M

-49.35%-7.73M

-59.03%-5.23M

-28.58%-17.78M

-42.15%-4.56M

-2.48%-4.75M

-47.28%-5.18M

-33.30%-3.29M

Net non-operating interest income expense

31.67%494.23K

-35.11%106.27K

-30.87%106K

116.91%129.93K

9,308.66%152.04K

2,904.06%375.36K

61,239.70%163.78K

3,017.77%153.33K

915.07%59.9K

-217.26%-1.65K

Non-operating interest income

31.67%494.23K

----

116.91%129.93K

----

--375.36K

----

--59.9K

----

Total other finance cost

----

30.87%-106K

----

-9,308.66%-152.04K

----

-3,017.77%-153.33K

----

217.26%1.65K

Other net income (expense)

-346.89%-429.35K

-105.34%-408.51K

89.00%82.2K

-249.69%-60.2K

-323.58%-42.84K

-31.75%-96.07K

-911.13%-198.94K

258.66%43.49K

190.63%40.21K

3.36%19.16K

Gain on sale of security

-346.89%-429.35K

-105.34%-408.51K

89.00%82.2K

-249.69%-60.2K

-323.58%-42.84K

-31.75%-96.07K

-911.13%-198.94K

258.66%43.49K

190.63%40.21K

3.36%19.16K

Income before tax

-26.81%-22.19M

-2.46%-4.71M

-3.13%-4.7M

-50.93%-7.66M

-56.55%-5.12M

-26.00%-17.5M

-42.38%-4.6M

2.24%-4.55M

-42.87%-5.08M

-33.67%-3.27M

Income tax

-14.74%79.28K

-81.43%14.5K

430.04%21.46K

190.72%26.59K

897.50%16.73K

2,219.76%92.98K

1,047.42%78.11K

-20.84%4.05K

149.89%9.15K

-51.80%1.68K

Net income

-26.59%-22.27M

-1.06%-4.72M

-3.51%-4.72M

-51.18%-7.69M

-56.98%-5.14M

-26.64%-17.59M

-45.17%-4.67M

2.26%-4.56M

-42.98%-5.09M

-33.55%-3.27M

Net income continuous Operations

-26.59%-22.27M

-1.06%-4.72M

-3.51%-4.72M

-51.18%-7.69M

-56.98%-5.14M

-26.64%-17.59M

-45.17%-4.67M

2.26%-4.56M

-42.98%-5.09M

-33.55%-3.27M

Minority interest income

Net income attributable to the parent company

-26.59%-22.27M

-1.06%-4.72M

-3.51%-4.72M

-51.18%-7.69M

-56.98%-5.14M

-26.64%-17.59M

-45.17%-4.67M

2.26%-4.56M

-42.98%-5.09M

-33.55%-3.27M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-26.59%-22.27M

-1.06%-4.72M

-3.51%-4.72M

-51.18%-7.69M

-56.98%-5.14M

-26.64%-17.59M

-45.17%-4.67M

2.26%-4.56M

-42.98%-5.09M

-33.55%-3.27M

Basic earnings per share

-15.54%-1.71

25.64%-0.29

2.63%-0.37

-44.19%-0.62

-53.57%-0.43

-8.03%-1.48

-50.00%-0.39

2.56%-0.38

-43.33%-0.43

44.00%-0.28

Diluted earnings per share

-15.54%-1.71

25.64%-0.29

2.63%-0.37

-44.19%-0.62

-53.57%-0.43

-8.03%-1.48

-50.00%-0.39

2.56%-0.38

-43.33%-0.43

44.00%-0.28

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	-60.62%55.18K	0	0	0	22.61%55.18K	-15.08%140.11K	0	0	6.65%95.1K	754.17%45.01K
Operating revenue	-58.40%55.18K	--0	--0	--0	47.00%55.18K	-0.96%132.64K	--0	--0	16.52%95.1K	--37.54K
Cost of revenue
Gross profit
Operating expense	24.51%22.31M	-3.38%4.41M	2.82%4.89M	46.66%7.73M	58.54%5.28M	28.06%17.92M	40.26%4.56M	1.88%4.75M	46.28%5.27M	34.84%3.33M
Selling and administrative expenses	13.08%10.79M	-11.11%2.03M	-9.64%2.52M	39.19%3.74M	40.33%2.49M	39.74%9.54M	28.54%2.29M	27.43%2.79M	48.56%2.69M	69.13%1.78M
-General and administrative expense	13.08%10.79M	-11.11%2.03M	-9.64%2.52M	39.19%3.74M	40.33%2.49M	39.74%9.54M	28.54%2.29M	27.43%2.79M	48.56%2.69M	69.13%1.78M
Research and development costs	37.52%11.52M	4.40%2.37M	20.50%2.37M	54.44%3.99M	79.33%2.79M	16.93%8.38M	54.42%2.27M	-20.67%1.96M	43.98%2.58M	9.49%1.56M
Operating profit	-25.18%-22.25M	3.38%-4.41M	-2.82%-4.89M	-49.35%-7.73M	-59.03%-5.23M	-28.58%-17.78M	-42.15%-4.56M	-2.48%-4.75M	-47.28%-5.18M	-33.30%-3.29M
Net non-operating interest income expense	31.67%494.23K	-35.11%106.27K	-30.87%106K	116.91%129.93K	9,308.66%152.04K	2,904.06%375.36K	61,239.70%163.78K	3,017.77%153.33K	915.07%59.9K	-217.26%-1.65K
Non-operating interest income	31.67%494.23K	----	----	116.91%129.93K	----	--375.36K	----	----	--59.9K	----
Total other finance cost	----	----	30.87%-106K	----	-9,308.66%-152.04K	----	----	-3,017.77%-153.33K	----	217.26%1.65K
Other net income (expense)	-346.89%-429.35K	-105.34%-408.51K	89.00%82.2K	-249.69%-60.2K	-323.58%-42.84K	-31.75%-96.07K	-911.13%-198.94K	258.66%43.49K	190.63%40.21K	3.36%19.16K
Gain on sale of security	-346.89%-429.35K	-105.34%-408.51K	89.00%82.2K	-249.69%-60.2K	-323.58%-42.84K	-31.75%-96.07K	-911.13%-198.94K	258.66%43.49K	190.63%40.21K	3.36%19.16K
Income before tax	-26.81%-22.19M	-2.46%-4.71M	-3.13%-4.7M	-50.93%-7.66M	-56.55%-5.12M	-26.00%-17.5M	-42.38%-4.6M	2.24%-4.55M	-42.87%-5.08M	-33.67%-3.27M
Income tax	-14.74%79.28K	-81.43%14.5K	430.04%21.46K	190.72%26.59K	897.50%16.73K	2,219.76%92.98K	1,047.42%78.11K	-20.84%4.05K	149.89%9.15K	-51.80%1.68K
Net income	-26.59%-22.27M	-1.06%-4.72M	-3.51%-4.72M	-51.18%-7.69M	-56.98%-5.14M	-26.64%-17.59M	-45.17%-4.67M	2.26%-4.56M	-42.98%-5.09M	-33.55%-3.27M
Net income continuous Operations	-26.59%-22.27M	-1.06%-4.72M	-3.51%-4.72M	-51.18%-7.69M	-56.98%-5.14M	-26.64%-17.59M	-45.17%-4.67M	2.26%-4.56M	-42.98%-5.09M	-33.55%-3.27M
Minority interest income
Net income attributable to the parent company	-26.59%-22.27M	-1.06%-4.72M	-3.51%-4.72M	-51.18%-7.69M	-56.98%-5.14M	-26.64%-17.59M	-45.17%-4.67M	2.26%-4.56M	-42.98%-5.09M	-33.55%-3.27M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-26.59%-22.27M	-1.06%-4.72M	-3.51%-4.72M	-51.18%-7.69M	-56.98%-5.14M	-26.64%-17.59M	-45.17%-4.67M	2.26%-4.56M	-42.98%-5.09M	-33.55%-3.27M
Basic earnings per share	-15.54%-1.71	25.64%-0.29	2.63%-0.37	-44.19%-0.62	-53.57%-0.43	-8.03%-1.48	-50.00%-0.39	2.56%-0.38	-43.33%-0.43	44.00%-0.28
Diluted earnings per share	-15.54%-1.71	25.64%-0.29	2.63%-0.37	-44.19%-0.62	-53.57%-0.43	-8.03%-1.48	-50.00%-0.39	2.56%-0.38	-43.33%-0.43	44.00%-0.28
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall